Cited by 164Acute Lymphoblastic Leukemia researchInflammasome and immune disordersAcute Myeloid Leukemia Research

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

Open access
Paugh, Steven W, Bonten, Erik J, Savic, Daniel, Ramsey, Laura B, Thierfelder, William E, Gurung, Prajwal, Malireddi, R K Subbarao, Actis, Marcelo +37 more·2015·Nature Genetics

Abstract

Glucocorticoids are universally used in the treatment of acute lymphoblastic leukemia (ALL), and resistance to glucocorticoids in leukemia cells confers poor prognosis. To elucidate mechanisms of glucocorticoid resistance, we determined the prednisolone sensitivity of primary leukemia cells from 444 patients newly diagnosed with ALL and found significantly higher expression of CASP1 (encoding caspase 1) and its activator NLRP3 in glucocorticoid-resistant leukemia cells, resulting from significantly lower somatic methylation of the CASP1 and NLRP3 promoters. Overexpression of CASP1 resulted in cleavage of the glucocorticoid receptor, diminished the glucocorticoid-induced transcriptional response and increased glucocorticoid resistance. Knockdown or inhibition of CASP1 significantly increased glucocorticoid receptor levels and mitigated glucocorticoid resistance in CASP1-overexpressing ALL. Our findings establish a new mechanism by which the NLRP3-CASP1 inflammasome modulates cellular levels of the glucocorticoid receptor and diminishes cell sensitivity to glucocorticoids. The broad impact on the glucocorticoid transcriptional response suggests that this mechanism could also modify glucocorticoid effects in other diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.3283

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peripheral T cell trafficking in response to glucocorticoids is impaired in patients with depression, possibly due to glucocorticoid resistance from genetically mediated or inflammasome-mediated mechanisms targeting the glucocorticoid receptor.

    “Relevant to depression, however, peripheral T cell trafficking in response to glucocorticoids has been shown to be impaired in patients with depression, possibly owing to glucocorticoid resistance as a result of genetically mediated (for example, FKBP5) or inflammasome-mediated mechanisms targeting the glucocorticoid receptor46,115.”

    From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [46]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids.

    “NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Paugh, S. W., Bonten, E. J., Savic, D., Ramsey, L. B., Thierfelder, W. E., Gurung, P., Malireddi, R. K. S., Actis, M., Mayasundari, A., Min, J., Coss, D. R., Laudermilk, L. T., Panetta, J. C., McCorkle, J. R., Fan, Y., Crews, K. R., Stocco, G., Wilkinson, M. R., Ferreira, A. M., Cheng, C., Yang, W., Karol, S. E., Fernandez, C. A., Diouf, B., Smith, C., Hicks, J. K., Zanut, A., Giordanengo, A., Crona, D., Bianchi, J. J., Holmfeldt, L., Mullighan, C. G., den Boer, M. L., Pieters, R., Jeha, S., Dunwell, T. L., Latif, F., Bhojwani, D., Carroll, W. L., Pui, C.-H., Myers, R. M., Guy, R. K., Kanneganti, T.-D., Relling, M. V., & Evans, W. E.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • HudsonAlpha Institute for Biotechnology (US)
  • Erasmus MC (NL)
  • University of Birmingham (GB)
  • NYU Langone Health (US)
Corresponding author
Evans, William E
Venue
Nature Genetics
Published
2015-05-04
Volume
47
Issue
6
Pages
607-614
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W1559296648
Cited by
164
References
53
Citations by year
2026: 8 · 2025: 14 · 2024: 15 · 2023: 13 · 2022: 13 · 2021: 16 · 2020: 19 · 2019: 18 · 2018: 18 · 2017: 5 · 2016: 19 · 2015: 5 · 2012: 1
FWCI
16.76
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • National Institutes of Health (CA21765))
  • National Cancer Institute (R37-CA36401, R01CA163507, GM92666, CA21765, F32CA141762, R37CA036401, 21765, R25CA023944, P30CA021765)
  • National Institute of General Medical Sciences (U01GM92666, U01GM092666)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Acute Lymphoblastic Leukemia research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
NLRP3 inflammasome, caspase-1, glucocorticoid resistance, acute lymphoblastic leukemia, DNA methylation, promoter methylation, inflammation
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Adolescent, Base Sequence, Carrier Proteins, Child, Child, Preschool, Drug Screening Assays, Antitumor, Humans, Infant, Infant, Newborn, Neoplasm Recurrence, Local, Prednisolone, Receptors, Glucocorticoid, Transcription, Genetic, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Leukemic, Antineoplastic Agents, Hormonal, Drug Resistance, Neoplasm, DNA Methylation, Caspase 1, Precursor Cell Lymphoblastic Leukemia-Lymphoma, HEK293 Cells, Inflammasomes, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review